Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of maspin in cancer.
Berardi R, Morgese F, Onofri A, Mazzanti P, Pistelli M, Ballatore Z, Savini A, De Lisa M, Caramanti M, Rinaldi S, Pagliaretta S, Santoni M, Pierantoni C, Cascinu S. Berardi R, et al. Among authors: pagliaretta s. Clin Transl Med. 2013 Mar 7;2(1):8. doi: 10.1186/2001-1326-2-8. Clin Transl Med. 2013. PMID: 23497644 Free PMC article.
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients.
Morgese F, Soldato D, Pagliaretta S, Giampieri R, Brancorsini D, Torniai M, Rinaldi S, Savini A, Onofri A, Scarpelli M, Berardi R. Morgese F, et al. Among authors: pagliaretta s. Oncotarget. 2017 May 30;8(44):75914-75923. doi: 10.18632/oncotarget.18304. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100280 Free PMC article.
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms.
Berardi R, Torniai M, Partelli S, Rubini C, Pagliaretta S, Savini A, Polenta V, Santoni M, Giampieri R, Onorati S, Barucca F, Murrone A, Bianchi F, Falconi M. Berardi R, et al. Among authors: pagliaretta s. PLoS One. 2018 May 22;13(5):e0197035. doi: 10.1371/journal.pone.0197035. eCollection 2018. PLoS One. 2018. PMID: 29787601 Free PMC article.
Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer.
Berardi R, Santoni M, Morgese F, Ballatore Z, Savini A, Onofri A, Mazzanti P, Pistelli M, Pierantoni C, De Lisa M, Caramanti M, Pagliaretta S, Pellei C, Cascinu S. Berardi R, et al. Among authors: pagliaretta s. Onco Targets Ther. 2013 May 21;6:563-76. doi: 10.2147/OTT.S28155. Print 2013. Onco Targets Ther. 2013. PMID: 23723712 Free PMC article.
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach.
Berardi R, Goteri G, Brunelli A, Pagliaretta S, Paolucci V, Caramanti M, Rinaldi S, Refai M, Pompili C, Morgese F, Torniai M, Marcantognini G, Ricci G, Mazzanti P, Onofri A, Bianchi F, Sabbatini A, Cascinu S. Berardi R, et al. Among authors: pagliaretta s. Expert Opin Ther Targets. 2020 Sep;24(9):937-943. doi: 10.1080/14728222.2020.1790529. Epub 2020 Jul 23. Expert Opin Ther Targets. 2020. PMID: 32662701
The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions.
Berardi R, Goteri G, Pagliaretta S, Paolucci V, Morgese F, Conti A, Refai M, Pompili C, Duranti C, Marcantognini G, Savini A, Caramanti M, Rinaldi S, Torniai M, Santoni M, Zizzi A, Mazzanti P, Onofri A, Ricci G, Scarpelli M. Berardi R, et al. Among authors: pagliaretta s. J Thorac Dis. 2020 Dec;12(12):7245-7256. doi: 10.21037/jtd-19-3720. J Thorac Dis. 2020. PMID: 33447413 Free PMC article.
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy.
Berardi R, Brunelli A, Pagliaretta S, Paolucci V, Conti A, Goteri G, Refai M, Pompili C, Marcantognini G, Morgese F, Ballatore Z, Savini A, De Lisa M, Caramanti M, Santoni M, Zizzi A, Piva F, Mazzanti P, Onofri A, Sabbatini A, Scarpelli M, Cascinu S. Berardi R, et al. Among authors: pagliaretta s. Oncotarget. 2015 Aug 7;6(22):19305-15. doi: 10.18632/oncotarget.4191. Oncotarget. 2015. PMID: 26254278 Free PMC article.
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type.
Maccaroni E, Lenci E, Agostinelli V, Cognigni V, Giampieri R, Mazzanti P, Di Pietro Paolo M, Bianchi F, Brugiati C, Belvederesi L, Pagliaretta S, Mandolesi A, Scarpelli M, Murrone A, Morgese F, Ballatore Z, Berardi R. Maccaroni E, et al. Among authors: pagliaretta s. Explor Target Antitumor Ther. 2021;2(3):240-248. doi: 10.37349/etat.2021.00044. Epub 2021 Jun 28. Explor Target Antitumor Ther. 2021. PMID: 36046437 Free PMC article.
16 results